These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8396634)

  • 41. Contralateral, ipsilateral and bilateral treatments with the kappa-opioid receptor agonist U-50,488H in mononeuropathic rats.
    Bileviciute-Ljungar I; Spetea M
    Eur J Pharmacol; 2004 Jun; 494(2-3):139-46. PubMed ID: 15212967
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Schild (apparent pA2) analysis of a kappa-opioid antagonist in Planaria.
    Raffa RB; Baron DA; Tallarida RJ
    Eur J Pharmacol; 2006 Jul; 540(1-3):200-1. PubMed ID: 16737694
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of neural and neuroendocrine activity by alpha-interferon: neuroendocrine, electrophysiological, and biochemical studies in the rat.
    Saphier D; Roerig SC; Ito C; Vlasak WR; Farrar GE; Broyles JE; Welch JE
    Brain Behav Immun; 1994 Mar; 8(1):37-56. PubMed ID: 8003770
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of a selective kappa-opioid agonist, U-50,488H, on morphine dependence in rats.
    Fukagawa Y; Katz JL; Suzuki T
    Eur J Pharmacol; 1989 Oct; 170(1-2):47-51. PubMed ID: 2558895
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multi-dimensional analyses of behavior in mice treated with U-50,488H, a purported kappa (non-mu) opioid agonist.
    Ukai M; Kameyama T
    Brain Res; 1985 Jul; 337(2):352-6. PubMed ID: 2992682
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of beta-funaltrexamine on opioid side-effects produced by morphine and U-50, 488H.
    Hayes AG; Skingle M; Tyers MB
    J Pharm Pharmacol; 1985 Nov; 37(11):841-3. PubMed ID: 2867174
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Naloxone-induced analgesia: involvement of kappa-opiate receptors.
    Bianchi M; Panerai AE
    Pharmacol Biochem Behav; 1993 Sep; 46(1):145-8. PubMed ID: 8255904
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Naloxone benzoylhydrazone, a kappa 3 opioid agonist, stimulates food intake in rats.
    Koch JE; Pasternak GW; Arjune D; Bodnar RJ
    Brain Res; 1992 May; 581(2):311-4. PubMed ID: 1327401
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of the kappa-opioid agonist U50,488 on parturition in rats.
    Douglas AJ; Clarke G; MacMillan SJ; Bull PM; Neumann I; Way SA; Wright DM; McGrory BG; Russell JA
    Br J Pharmacol; 1993 May; 109(1):251-8. PubMed ID: 8388299
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Kappa opioid partial agonist activity of the enkephalin-like pentapeptide BW942C based on urination and in vitro studies in humans and animals.
    Vaupel DB; Cone EJ; Johnson RE; Su TP
    J Pharmacol Exp Ther; 1990 Jan; 252(1):225-34. PubMed ID: 2153801
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential effects of LY235959, a competitive antagonist of the NMDA receptor on kappa-opioid receptor agonist induced responses in mice and rats.
    Bhargava HN; Thorat SN
    Brain Res; 1997 Feb; 747(2):246-51. PubMed ID: 9045999
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Altered neurochemical and behavioral development of 10-day-old rats perinatally exposed to the kappa opioid agonist U-50,488H.
    Shieh GJ; Walters DE
    Neurosci Lett; 1994 Jul; 176(1):37-40. PubMed ID: 7970232
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of naloxone, morphine and kappa-opioid receptor agonists on hypoxia/hypoglycemia-induced reduction of 2-deoxyglucose uptake in hippocampal slices from U-50,488H-tolerant rats.
    Shibata S; Tominaga K; Watanabe S
    Neurosci Lett; 1994 Dec; 182(2):155-8. PubMed ID: 7715801
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Central kappa opioid receptor-evoked changes in renal function in conscious rats: participation of renal nerves.
    Kapusta DR; Obih JC
    J Pharmacol Exp Ther; 1993 Oct; 267(1):197-204. PubMed ID: 8229746
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nitric oxide synthase inhibition blocks tolerance to the analgesic action of kappa-opiate receptor agonist in the rat.
    Bhargava HN
    Pharmacology; 1994 Apr; 48(4):234-41. PubMed ID: 7513892
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The kappa-opioid receptor agonist, U50,488H, exerts antidystonic activity in a mutant hamster model of generalized dystonia.
    Richter A; Löscher W
    Eur J Pharmacol; 1993 May; 236(2):289-94. PubMed ID: 8391460
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Binding characteristics of [3H]SCH 23390 in spinal cord and discrete brain regions of kappa-opiate tolerant-dependent and abstinent rats.
    Bhargava HN; Gulati A; Ramarao P
    Pharmacology; 1991; 42(3):121-7. PubMed ID: 1647533
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Methionine-enkephalin concentrations in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of U-50,488H-tolerant and abstinent rats.
    Tejwani GA; Rattan AK; Koo KL; Matwyshyn GA; Bhargava HN
    Pharmacology; 1994 Apr; 48(4):216-25. PubMed ID: 8177908
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of dizocilpine (MK-801) on analgesia and tolerance induced by U-50,488H, a kappa-opioid receptor agonist, in the mouse.
    Bhargava HN; Thorat SN
    Brain Res; 1994 Jun; 649(1-2):111-6. PubMed ID: 7953621
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhancement of a kappa-opioid receptor agonist-induced analgesia by L-tyrosine and L-tryptophan.
    Barjavel MJ; Thorat SN; Bhargava HN
    Eur J Pharmacol; 1994 Jun; 258(3):173-8. PubMed ID: 8088353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.